20
Pierre Fabre Medicament Gaillac Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for The 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group.
One of their significant offerings is Ossein Hydroxyapatite Compound, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-047 - Rev 03
This TSE Type CEP, issued on January 22, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.